Friedman Lab

Sloan-Kettering Inst Can Research

New York · United States

NIH-funded
Rate this labNo reviews yet — be the first.

Research focus

NIH R01 · 2024

Decreasing Cardiometabolic Risk in Survivors of Childhood Cancer: Survivors engaged in Time-Restricted EatiNG after THerapy (STRENGTH)

PROJECT SUMMARY Over 500,000 survivors of childhood cancer are living in the United States today. Cardiovascular disease is the leading cause of noncancer late mortality in this cohort. Subgroups of survivors, including individuals previously exposed to radiation to the chest, abdomen, and total body, are also at treatment-related risk for a constellation of cardiometabolic comorbidities, including type 2 diabetes mellitus, chronic inflammation, and hypertension, which further amplifies their risk of cardiovascular disease. Tailored, scalable and sustainable interventions that target modifiable risk factors, such as obesity, are thus urgently needed to reduce cardiometabolic risk in this…

From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.

Reviews

← All labs at Sloan-Kettering Inst Can Research